{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:01:59Z","timestamp":1649037719459},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1157\/13076174","type":"journal-article","created":{"date-parts":[[2005,6,22]],"date-time":"2005-06-22T12:22:07Z","timestamp":1119442927000},"page":"349-352","source":"Crossref","is-referenced-by-count":0,"title":["Determinaci\u00f3n de concentraciones plasm\u00e1ticas de efavirenz y nevirapina en pacientes hemof\u00edlicos con infecci\u00f3n por el VIH"],"prefix":"10.1016","volume":"23","author":[{"given":"Marta","family":"Martorell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Tural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Monterde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13076174_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002030-200101050-00011","article-title":"Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients","volume":"15","author":"Marzolini","year":"2001","journal-title":"AIDS"},{"key":"10.1157\/13076174_bib2","first-page":"309","article-title":"Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients","volume":"7","author":"Langmann","year":"2002","journal-title":"Eur J Med Res"},{"key":"10.1157\/13076174_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00126334-200112010-00015","article-title":"Higher efavirenz plasma levels correlate with development of insomnia","volume":"28","author":"N\u00fa\u00f1ez","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13076174_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00002030-200106150-00003","article-title":"High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals","volume":"15","author":"Veldkamp","year":"2001","journal-title":"AIDS"},{"key":"10.1157\/13076174_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-4347(99)00336-9","article-title":"Quantitative determination of efavirenz (DMP266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-perfomance liquid chromatography with ultraviolet detection","volume":"734","author":"Veldkamp","year":"1999","journal-title":"J Chromatography B"},{"key":"10.1157\/13076174_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0378-4347(00)00476-X","article-title":"Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatography","volume":"751","author":"L\u00f3pez","year":"2001","journal-title":"J Chromatogr B"},{"key":"10.1157\/13076174_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/320998","article-title":"The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons","volume":"184","author":"Veldkamp","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1157\/13076174_bib8","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00002030-199905070-00025","article-title":"High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease","volume":"13","author":"Maserati","year":"1999","journal-title":"AIDS"},{"key":"10.1157\/13076174_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/088922203763315687","article-title":"Interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-Infected patients","volume":"19","author":"N\u00fa\u00f1ez","year":"2003","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05749752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05749752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T05:56:04Z","timestamp":1548395764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X05749752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0213005X05749752"],"URL":"https:\/\/doi.org\/10.1157\/13076174","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}